DRAGONFLY THERAPEUTICS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 07 Feb 2024)
What this means for you
Registered since 22 Aug 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87092750
- Registration number
- 5272538
- Mark type
- Stylized text
- Filed
- 05 Jul 2016
- Published for opposition
- 20 Dec 2016
- Registered
- 22 Aug 2017
- Attorney of record
- Peter Kunin
Goods and services
- Class 042 — Scientific and technological services: Research and development of immunotherapy drugs for cancer treatment
Owner
- Dragonfly Therapeutics, Inc., Waltham, MA, US
- Dragonfly Therapeutics, Inc., One Kendall Square, MA, US
- Equipoise Therapeutics Corporation, One Kendall Square, MA, US
- Equipoise Therapeutics Corporation, One Kendall Square, MA, US
Prosecution history
- 07 Feb 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 07 Feb 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Aug 2023 — TEAS SECTION 8 & 15 RECEIVED
- 22 Aug 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Aug 2017 — REGISTERED-PRINCIPAL REGISTER
- 18 Jul 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Jul 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Jun 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 19 May 2017 — USE AMENDMENT FILED
- 19 Jun 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 May 2017 — TEAS STATEMENT OF USE RECEIVED
- 17 May 2017 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Feb 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Dec 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED